Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
96,015,846
Number of holders
60
Total 13F shares, excl. options
17,375,298
Shares change
+1,622,458
Total reported value, excl. options
$211,265,514
Value change
+$20,553,121
Put/Call ratio
26.71%
Number of buys
29
Number of sells
-26
Price
$12.16

Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2021

75 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2021.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,375,298 shares of 96,015,846 outstanding shares and own 18.1% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,041,645 shares), 5AM Venture Management, LLC (2,359,263 shares), Cormorant Asset Management, LP (1,611,623 shares), BOXER CAPITAL, LLC (1,603,361 shares), Ikarian Capital, LLC (1,187,898 shares), Point72 Asset Management, L.P. (900,000 shares), VANGUARD GROUP INC (730,781 shares), Redmile Group, LLC (696,377 shares), BAKER BROS. ADVISORS LP (662,063 shares), and CITADEL ADVISORS LLC (559,467 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.